Literature DB >> 7668211

Coronary lesions at increased risk.

S G Ellis1.   

Abstract

An acute ischemic complication will develop in approximately 7% of patients undergoing coronary angioplasty. In more than half of these patients, thrombus, dissection, or both can be identified angiographically as the underlying cause of abrupt closure; in the remaining cases, an indeterminate morphology is observed. Predictors of dissection-mediated closure include degenerated vein graft, de novo stenosis, proximal tortuosity, high lesion grade, eccentricity, longer lesion length, and angulation. Thrombus-medicated closure is most apt to occur in degenerated vein grafts, lesions related to a recent myocardial infarction, and lesions that contain thrombus before angioplasty. However, the ability of these parameters to predict risk in an individual patient is rather weak. Angioscopy has revealed that the presence of yellow plaque confers a heightened risk of major complications. Lesions that contain areas of calcium adjacent to areas to soft plaque have been identified by intravascular ultrasound as a powerful predictor a major dissection. These sensitive new imaging techniques may eventually permit the targeting of more specific therapies to the underlying cause of closure.

Entities:  

Mesh:

Year:  1995        PMID: 7668211     DOI: 10.1016/0002-8703(95)90300-3

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  3 in total

1.  Complications of coronary intervention: abrupt closure, dissection, perforation.

Authors:  Debabrata Dash
Journal:  Heart Asia       Date:  2013-05-03

2.  Mechanical buckling of veins under internal pressure.

Authors:  Ricky Martinez; Cesar A Fierro; Paula K Shireman; Hai-Chao Han
Journal:  Ann Biomed Eng       Date:  2010-01-22       Impact factor: 3.934

3.  Association between duration of coronary occlusion and high-intensity signal on T1-weighted magnetic resonance imaging among patients with angiographic total occlusion.

Authors:  Kenji Matsumoto; Shoichi Ehara; Takao Hasegawa; Mikumo Sakaguchi; Kenei Shimada
Journal:  Eur Radiol       Date:  2017-02-02       Impact factor: 5.315

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.